Multiple chemotherapeutic agents for Hodgkin disease. Comparison of three routines: a cooperative study by acute leukemia group B.
D000328:Adult; D000367:Age Factors; D001565:Benzoates / Q000627:therapeutic use; D004357:Drug Synergism; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D007962:Leukocytes / Q000187:drug effects; D008297:Male; D008466:Mechlorethamine / Q000627:therapeutic use*; D008875:Middle Aged; D009132:Muscles / Q000187:drug effects; D011241:Prednisone / Q000627:therapeutic use*; D011344:Procarbazine / Q000627:therapeutic use; D012075:Remission, Spontaneous; D012737:Sex Factors; D013431:Sulfates / Q000627:therapeutic use; D013997:Time Factors; D014750:Vincristine / Q000009:adverse effects / Q000627:therapeutic use*
D001565:Benzoates; D013431:Sulfates; D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D011241:Prednisone